invega hafyera paliperidone (as palmitate) 700 mg in 3.5 ml modified release suspension for injection pre-filled syringe
janssen-cilag pty ltd - paliperidone palmitate, quantity: 1092 mg - injection, suspension - excipient ingredients: polysorbate 20; macrogol 4000; citric acid monohydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; water for injections - invega hafyera, a 6-month injection, is indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months or the 3-month paliperidone palmitate injectable product following at least one 3-month injection cycle.
invega paliperidone tablet extended release
avera mckennan hospital - paliperidone (unii: 838f01t721) (paliperidone - unii:838f01t721) - paliperidone 6 mg
trevicta
j-c health care ltd - paliperidone as palmitate - extended release suspension for injection - paliperidone as palmitate 200 mg / 1 ml - paliperidone - trevicta, a 3 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly paliperidone palmitate injectable product
paliperidone palmitate kit
tolmar inc. - paliperidone palmitate (unii: r8p8usm8fr) (paliperidone - unii:838f01t721) -
invega hafyera- paliperidone palmitate injection, suspension, extended release
janssen pharmaceuticals, inc - paliperidone palmitate (unii: r8p8usm8fr) (paliperidone - unii:838f01t721) - invega hafyera, an every-six-month injection, is indicated for the treatment of schizophrenia in adults after they have been adequately treated with: - a once-a-month paliperidone palmitate extended-release injectable suspension (e.g., invega sustenna) for at least four months, or - an every-three-month paliperidone palmitate extended-release injectable suspension (e.g., invega trinza) for at least one three-month cycle. invega hafyera is contraindicated in patients with a known hypersensitivity to either paliperidone or risperidone, or to any of the excipients in the invega hafyera formulation. hypersensitivity reactions, including anaphylactic reactions and angioedema, have been reported in patients treated with risperidone and in patients treated with paliperidone. paliperidone palmitate is converted to paliperidone, which is a metabolite of risperidone. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotic
paliperidone teva 100 mg
teva israel ltd - paliperidone palmitate - suspension for injection extended release - paliperidone palmitate 100 mg / 1 ml - paliperidone - paliperidone teva® is indicated for the acute and maintenance treatment of schizophrenia in adults.paliperidone teva® is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants.
paliperidone teva 150 mg
teva israel ltd - paliperidone as palmitate - suspension for injection extended release - paliperidone as palmitate 100 mg / 1 ml - paliperidone - paliperidone teva® is indicated for the acute and maintenance treatment of schizophrenia in adults.paliperidone teva® is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants.
paliperidone teva 25 mg
teva israel ltd - paliperidone as palmitate - suspension for injection extended release - paliperidone as palmitate 100 mg / 1 ml - paliperidone - paliperidone teva® is indicated for the acute and maintenance treatment of schizophrenia in adults.paliperidone teva® is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants.
paliperidone teva 50 mg
teva israel ltd - paliperidone palmitate - suspension for injection extended release - paliperidone palmitate 100 mg / 1 ml - paliperidone - paliperidone teva® is indicated for the acute and maintenance treatment of schizophrenia in adults.paliperidone teva® is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants.
paliperidone teva 75 mg
teva israel ltd - paliperidone as palmitate - suspension for injection extended release - paliperidone as palmitate 100 mg / 1 ml - paliperidone - paliperidone teva® is indicated for the acute and maintenance treatment of schizophrenia in adults.paliperidone teva® is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants.